Skip to main content
FENCHealthcare

Fennec Pharmaceuticals Inc (FENC) Insider Trading

In the last 90 days, 4 Fennec Pharmaceuticals Inc (FENC) insiders reported no open-market purchases and 5 sales totaling $1,406,518. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 15, 2026Marco Maria BrugheraDirectorSale15,545$10.29$159,958
Sep 1, 2026Rosty RaykovCorporate insiderSale10,000$12.11$121,100
Aug 31, 2026Pierre Sargis SayadChief Medical OfficerSale12,000$12.18$146,160
Aug 27, 2026Robert AndradeCHIEF FINANCIAL OFFICERSale75,000$11.78$883,500
Aug 3, 2026Rosty RaykovCorporate insiderSale10,000$9.58$95,800
Jul 1, 2026Rosty RaykovCorporate insiderSale9,599$10.41$99,926
Jun 1, 2026Rosty RaykovDirectorSale9,747$9.62$93,766
May 11, 2026Chris A RallisDirectorSale8,346$7.04$58,756
May 1, 2026Rosty RaykovDirectorSale10,781$6.47$69,753

Common questions

FENC insider trading FAQ

Are FENC insiders buying or selling?
Over the last 90 days, FENC insiders were net sellers, reporting $0.00 of open-market purchases and $1,406,518 of sales.
When was the last FENC insider purchase?
No open-market insider purchase of Fennec Pharmaceuticals Inc stock was reported in the last 90 days.
Where does FENC insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Fennec Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.